Diagnosis Antifungal susceptibility Serodiagnosis Genomic diversity Glucocorticoids Essential oil Cryptococcal meningitis Epidemiological cut-off values Non-human primates Fungaemia Cytochrome b CRISPR-Cas9 Echinocandins Aspergillosis Selective pressure Airway microbiome Treatment Transmission Particulate matter Rheumatoid Gradient concentration strip–specific Atovaquone PIG1 3-beta-D-glucan Serology Ocular toxoplasmosis Cryptococcosis RNA-seq Mucormycosis Heptane Glioblastoma Radioresistance Ceruloplasmin Iron Metabolism Hypoxia CYB Anti-inflammatory Pneumocystis jirovecii cytochrome b CYB atovaquone selective pressure Solid-organ transplantation Diversité génétique Scedosporium apiospermum Antiparasitaire Smoking HIV-seronegative Diversité génomique P jirovecii Pneumocystis jirovecii dhfr dihydrofolate reductase genetic diversity methotrexate Toxoplasmose oculaire Traitement Autoimmune Diseases Malaria Plasmodium P falciparum Molecular diagnosis qPCR LAMP Bio-Evolution Biosynex Mycobiome Hot spots Penicillium Uveitis Candidemia Invasive fungal infections Malignancy Catharanthus roseus Selection Apocynaceae IMPDH Multiplex PCR Gastrointestinal protozoa Molecular approach PCR panel Arthritis Anti-parasitic Méthotrexate Monoterpene indole alkaloids Fungemia Mycophenolic acid C glabrata Co-product valorization Pneumocystis jirovecii gsc1 1 3-beta-D-glucan echinocandins genomic diversity hot spots Genotypes Dhfr Methotrexate Infections Cell wall Dogs Delphi method Non-tuberculous mycobacteria Aspergillus C albicans Transplantation Exposome Epidemiology Gsc1 DHN-melanin Human immunodeficiency virus Coproscopy Digestive parasites Delphi study Commiphora wildii Anti-inflammatoire Pneumocytosis ELISA Antirheumatic Agents Candida Environment Cystic fibrosis Pneumocystis jirovecii Dihydrofolate reductase Talaromyces Genetic diversity